Hepatitis B Linked to Pancreatic Cancer; CBCD Reviews New Evidence

Industry: Health & Fitness

Hepatitis B is strongly linked to pancreatic cancer. The CBCD reviews the evidence and recommends two hepatitis B remedies.

New York (PRUnderground) June 20th, 2014

“Infected with the hepatitis B virus (HBV)? We recommend taking Gene-Eden-VIR or Novirin.” – Greg Bennett, CBCD

The hepatitis B virus (HBV) is strongly linked to pancreatic cancer. As Dr. Majumder and his team wrote in a recent meta-analysis “BsAg positivity (an HBV protein) is associated with an increased risk of pancreatic cancer.” (1) Dr. Majumder and his colleagues are from the Department of Internal Medicine, University of Connecticut Health Center. Dr. Majumder’s findings are important since pancreatic cancer is projected to become the second leading cause of cancer deaths by 2030. Lynn Matrisian, PhD said that “The projections for deaths from pancreatic and liver cancers are startling.” (2) Dr. Matrisian is the vice president of scientific and medical affairs at the Pancreatic Cancer Action Network. According to Dr. Matrisian, one of the major factors in pancreatic cancer incidence and death is “prevalence of smoking and viral infections.” (2)

The CBCD therefore recommends that people infected with hepatitis B (HBV) take Gene-Eden-VIR or Novirin. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the EBV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with a (latent virus)…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (3) The study authors also wrote that “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (3)

Both products can be ordered online on the Gene-Eden-VIR and Novirin websites.

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.

Dr. Fiorino and colleagues agree with Dr. Majumder. They wrote that “Hepatitis B (HBV) and hepatitis C virus (HCV) possess well-known oncogenic properties (cancer development) and … have been also detected in different extra-hepatic tissues, including the pancreas… (and) … epidemiological studies and meta-analyses have recently suggested that HBV/HCV may be also risk factors for pancreatic cancer.” (4) Dr. Fiorino and colleagues are from the Unit of Internal Medicine, Hospital of Budrio in Italy.

Pancreatic cancer is projected to surpass breast, prostate, and colorectal cancers to become the second leading causes of cancer death according to the pancreatic Cancer Action Network in Manhattan Beach, California.

The CBCD recommends that individuals infected with hepatitis B take Gene-Eden-VIR or Novirin.


(1)   Majumder S1, Bockorny B, Baker WL, Dasanu CA. Association Between HBsAg Positivity and Pancreatic Cancer: a Meta-Analysis. J Gastrointest Cancer. 2014 May 2.

(2)   Boltz, K Pancreatic cancer to become second-leading cause of cancer death by 2030. May 30, 2014

(3)   Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8 http://dx.doi.org/10.4236/pp.2013.46A001

(4)   Fiorino S1, Bacchi-Reggiani L, Pontoriero L, Gallo C, Chili E, Masetti M, Zanini N, Grondona A, Silvestri T, Deleonardi G, Fornelli A, Bondi A, de Biase D, Baccarini P, Tallini G, Tropeano A, Quartuccio V, Cuppini A, Castellani G, Jovine E. Tensegrity model hypothesis: may this paradigm be useful to explain hepatic and pancreatic carcinogenesis in patients with persistent hepatitis B or hepatitis C virus infection? JOP. 2014 Mar 10;15(2):151-64. 

About CBCD

About CBCD

The Center for the Biology of Chronic Disease (http://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Become a Fan

Press Contact

Mike Evans